title: Receiving enzyme replacement therapy for a lysosomal storage disorder: a preliminary exploration of the experiences of young patients and their families.
abstract: Medical intervention for lysosomal storage disorders becomes part of life, shaping the reality of the condition for affected individuals and families. Enzyme replacement therapy (ERT) is available to treat some lysosomal storage disorders. ERT is costly and time consuming, requiring frequent hospital visits to receive intravenous infusions. This qualitative study sought to explore the impact of receiving ERT for a lysosomal storage disorder on the health related quality of life (HRQoL) of young patients and their families. Fifteen semi-structured interviews were conducted with young people and parents and siblings of young people accessing ERT for Pompe disease, Gaucher disease or mucopolysaccharidosis types I or II living in Victoria, Australia. Interviews were transcribed then analyzed thematically. The biopsychosocial model assisted in interpreting themes. Findings revealed positive attitudes towards ERT, with noticed improvements in physical and psychosocial well-being. Participants prioritised intervention over other activities and provided suggestions for improving current service delivery. Communication with family members and professionals was deemed important, especially in respect to information provision. Participants described challenges associated with living with a lysosomal storage disorder and receiving ERT and coping strategies, such as positive thinking and ways to manage uncertainty. These findings provide valuable insights into the impact of living with a chronic genetic condition and receiving intensive treatment on HRQoL.
authors.affiliation: Department of Paediatrics, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria, Australia. Rebecca.Freedman@health.wa.gov.au
authors.forename: R
authors.initials: R
authors.lastname: Freedman
authors.forename: M
authors.initials: M
authors.lastname: Sahhar
authors.forename: L
authors.initials: L
authors.lastname: Curnow
authors.forename: J
authors.initials: J
authors.lastname: Lee
authors.forename: H
authors.initials: H
authors.lastname: Peters
mesh_terms: D000328:Adult; D056947:Enzyme Replacement Therapy; D005260:Female; D006801:Humans; D016464:Lysosomal Storage Diseases / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D011788:Quality of Life; D055815:Young Adult
references.citation: Eur J Pediatr. 2003 Dec;162 Suppl 1:S34-7
references.pmid: 14610674
references.citation: J Inherit Metab Dis. 2011 Feb;34(1):203-8
references.pmid: 20978944
references.citation: Qual Health Res. 2010 Aug;20(8):1076-90
references.pmid: 20442344
references.citation: Acta Neurol Belg. 2006 Jun;106(2):82-6
references.pmid: 16898258
references.citation: J Pediatr Nurs. 2009 Dec;24(6):448-57
references.pmid: 19931142
references.citation: Hum Genet. 2007 Mar;121(1):1-22
references.pmid: 17089160
references.citation: Qual Health Res. 2006 Dec;16(10):1414-35
references.pmid: 17079802
references.citation: J Pediatr. 2008 May;152(5):723-7
references.pmid: 18410781
references.citation: J Genet Couns. 1997 Dec;6(4):379-92
references.pmid: 26140908
references.citation: J Child Health Care. 2006 Sep;10(3):228-39
references.pmid: 16940345
references.citation: J Pediatr. 2009 Jan;154(1):135-9
references.pmid: 19187736
references.citation: Lancet Neurol. 2004 Dec;3(12):752-6
references.pmid: 15556808
references.citation: Qual Health Res. 2010 Dec;20(12):1677-88
references.pmid: 20729503
references.citation: J Pediatr. 2004 May;144(5 Suppl):S3-14
references.pmid: 15126978
references.citation: Paediatr Child Health. 2008 Mar;13(3):173-8
references.pmid: 19252693
references.citation: Eur J Pediatr. 2008 Mar;167(3):267-77
references.pmid: 18038146
references.citation: Qual Health Res. 2007 Dec;17(10):1372-80
references.pmid: 18000076
references.citation: Eur J Hum Genet. 2011 Jun;19(6):640-6
references.pmid: 21326287
references.citation: Am J Med Genet A. 2010 Aug;152A(8):2002-10
references.pmid: 20635362
references.citation: Baillieres Clin Haematol. 1997 Dec;10(4):779-92
references.pmid: 9497864
references.citation: Br J Nurs. 2007 Dec 13-2008 Jan 9;16(22):1384, 1386-9
references.pmid: 18361386
references.citation: J Pediatr. 2004 May;144(5 Suppl):S27-34
references.pmid: 15126981
references.citation: J Pediatr Psychol. 2002 Dec;27(8):699-710
references.pmid: 12403860
references.citation: J Affect Disord. 2000 Jun;58(3):181-99
references.pmid: 10802127
references.citation: Qual Health Res. 2008 Apr;18(4):441-57
references.pmid: 18354044
references.citation: Qual Health Res. 2008 Jul;18(7):1001-11
references.pmid: 18552326
references.citation: J Clin Nurs. 2006 Jan;15(1):61-71
references.pmid: 16390525
references.citation: J Clin Nurs. 2008 Jul;17(14):1823-33
references.pmid: 18578756
references.citation: Mol Genet Metab. 2007 Feb;90(2):171-80
references.pmid: 17011223
references.citation: J Pediatr Psychol. 1996 Apr;21(2):175-93
references.pmid: 8920152
references.citation: Child Care Health Dev. 2009 Mar;35(2):271-80
references.pmid: 19228160
references.citation: J Genet Couns. 2012 Feb;21(1):45-58
references.pmid: 21805222
references.citation: Mol Genet Metab. 2009 Jul;97(3):234-6
references.pmid: 19427803
references.citation: J Pediatr Psychol. 2004 Oct;29(7):565-70
references.pmid: 15347704
references.citation: J Child Health Care. 2006 Dec;10(4):309-25
references.pmid: 17101623
references.citation: Sch Inq Nurs Pract. 2000 Winter;14(4):299-319; discussion 321-6
references.pmid: 11372189
references.citation: J Pediatr. 2009 Oct;155(4 Suppl):S32-46
references.pmid: 19765409
references.citation: J Genet Couns. 2011 Feb;20(1):20-2
references.pmid: 20839038
references.citation: Br J Nurs. 2009 Dec 10-2010 Jan 13;18(22):1358, 1360-5
references.pmid: 20081690
references.citation: Child Care Health Dev. 2006 Jan;32(1):19-31
references.pmid: 16398788